[Indoleamine 2,3-dioxygenase 1 modulates the immuneresponse; the new therapeutic targets of this drug]

Nihon Yakurigaku Zasshi. 2013 Aug;142(2):85-8. doi: 10.1254/fpj.142.85.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Drug Design
  • Humans
  • Immunity / physiology*
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / antagonists & inhibitors
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / physiology*
  • Molecular Targeted Therapy*
  • Neoplasms / immunology
  • Neoplasms / metabolism

Substances

  • IDO1 protein, human
  • Indoleamine-Pyrrole 2,3,-Dioxygenase